Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up
The FDA greenlit 26 novel therapies in the first half of 2026, including four for cancer and six for orphan indications. Meanwhile, AstraZeneca and Johnson and Johnson took home a combined 11 of the…
Read the full articleYou might also wanna read
Medicinal plants used to treat infectious diseases in French Polynesia: an ethnobotanical survey and antibacterial evaluation
archimer.ifremer.fr·just now
A standardized method to monitor marine litter in submarine canyons: implementation in Atlantic and Mediterranean reef ecosystems
archimer.ifremer.fr·just now
Women in Nonequilibrium Statistical Physics, 7–11 Sep 2026 at KU Leuven (Belgium).
fys.kuleuven.be·just now
Oceanographic parameters associated with spatial occurrence of cephalopods in standardized demersal fishing trawls in the NE Atlantic
archimer.ifremer.fr·just now
BPI Asia Digital Series
bioprocessintl.com·just now
Quantum Computing Applications in QCD and Collider Physics: A Concise Overview
arxiv.org·20m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.